Beneficient CEO Silk James G. purchased 9,434 shares at $1.06 per share, with the transaction representing about 0.8% of his resulting holding. Investors can see the reported post-purchase position of 1,110,930 Beneficient shares alongside the transaction size and price.
Key Highlights
- Silk James G. used transaction code P for the Beneficient share purchase on 15 September 2026.
- The reported post-transaction Beneficient holding was 1,110,930 shares.
- The purchase represented about 0.8% of Silk James G.’s resulting shareholding.
The transaction took place on 15 September 2026 and left Silk James G. with 1,110,930 Beneficient (NASDAQ: BENF) shares.
9,434 Shares Purchased at $1.06
Silk James G. acquired the shares at the stated per-share price on 15 September 2026. Beneficient’s reported ownership figure after the transaction was 1,110,930 shares.
Purchase Equals About 0.8% of Resulting Holding
The 9,434-share transaction represented about 0.8% of Silk James G.’s resulting Beneficient shareholding. That percentage relates the purchase to the holding recorded after the transaction. The resulting position and the purchase size were both reported for Silk James G.’s Beneficient holdings. The stated price was $1.06 for each acquired share.
FAQs
Q: How many Beneficient shares did Silk James G. buy?
A: Silk James G. bought 9,434 Beneficient shares. The purchase price was $1.06 per share, and the transaction occurred on 15 September 2026.
Q: What was Silk James G.’s resulting Beneficient shareholding?
A: Silk James G. held 1,110,930 Beneficient shares after the purchase. He is identified as Beneficient’s Chief Executive Officer.
Q: What does transaction code P mean for the BENF stock purchase?
A: Transaction code P identifies an open-market purchase in SEC transaction coding. The Beneficient transaction involved 9,434 shares bought at $1.06 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.